These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22571761)

  • 1. Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus.
    Eickenberg S; Mickholz E; Jung E; Nofer JR; Pavenstadt HJ; Jacobi AM
    Arthritis Res Ther; 2012; 14(3):R110. PubMed ID: 22571761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    von Borstel A; Abdulahad WH; Dekkema G; Rutgers A; Stegeman CA; Veldman J; Heeringa P; Sanders JS
    PLoS One; 2020; 15(7):e0235743. PubMed ID: 32645052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.
    Feldman CH; Collins J; Zhang Z; Xu C; Subramanian SV; Kawachi I; Solomon DH; Costenbader KH
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1419-1424. PubMed ID: 30354025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
    Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
    Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
    Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
    Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
    Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative risks of cardiovascular disease events among SLE patients receiving immunosuppressive medications.
    Choi MY; Li D; Feldman CH; Yoshida K; Guan H; Kim SC; Everett BM; Costenbader KH
    Rheumatology (Oxford); 2021 Aug; 60(8):3789-3798. PubMed ID: 33369672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G; Tozman E; Nahar N; Metz D
    Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.
    Al Maimouni H; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1905-9. PubMed ID: 24821661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C; Vollenhoven Rv
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L; Deng J; Huo DM; Wu QY; Liao YH
    Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
    Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
    Abe Y; Tada K; Yamaji K; Tamura N
    Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.
    Bijl M; Horst G; Bootsma H; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2003 Jun; 62(6):534-9. PubMed ID: 12759290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K; Gladman DD; Su J; Urowitz MB
    J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.